Sino Biopharmaceutical Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sino Biopharmaceutical Limited with three other
companies in this sector in HONG KONG :
Hansoh Pharmaceutical Group Co Ltd
sales of 9.86 billion Hong Kong Dollars [US$1.27 billion]
of which 100%
was Sale of Pharmaceutical),
CSPC Pharmaceutical Group Ltd
(25.10 billion Hong Kong Dollars [US$3.24 billion]
of which 81%
was Finished Drugs), and
China Traditional Chinese Medicine Holdings Co Ltd
(16.26 billion Hong Kong Dollars [US$2.10 billion]
of which 64%
was Concentrated TCM Granules).
During the year ended December of 2019, sales at
Sino Biopharmaceutical Limited were HK$27.52 billion (US$3.55 billion).
increase of 11.3%
versus 2018, when the company's sales were HK$24.73 billion.
This was the fifth consecutive year of sales increases at Sino Biopharmaceutical Limited
(and since 2014, sales have increased a total of 122%).
Sales of Modernized Chinese Medicines and Chemica saw an increase
11.7% in 2019, from
HK$24.07 billion to HK$26.88 billion.
Not all segments of Sino Biopharmaceutical Limited experienced an increase in sales in 2019:
sales of Others fell 2.5% to HK$638.12 million.
(However, this segment's sales were only a very small portion of the company's overall sales).